Cerity Partners’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $452K | Buy |
400,267
+19,843
| +5% | +$22.4K | ﹤0.01% | 1916 |
|
|
2025
Q1 | $555K | Sell |
380,424
-6,963
| -2% | -$10.2K | ﹤0.01% | 1697 |
|
|
2024
Q4 | $832K | Sell |
387,387
-44,995
| -10% | -$96.6K | ﹤0.01% | 1506 |
|
|
2024
Q3 | $1.21M | Buy |
432,382
+232
| +0.1% | +$650 | ﹤0.01% | 1314 |
|
|
2024
Q2 | $1.01M | Buy |
432,150
+7,981
| +2% | +$18.6K | ﹤0.01% | 1222 |
|
|
2024
Q1 | $1.9M | Sell |
424,169
-93,412
| -18% | -$418K | 0.01% | 994 |
|
|
2023
Q4 | $1.66M | Buy |
+517,581
| New | +$1.66M | 0.01% | 814 |
|
|
2023
Q3 | – | Sell |
-598,100
| Closed | -$2.97M | – | 1397 |
|
|
2023
Q2 | $2.97M | Sell |
598,100
-1,954
| -0.3% | -$9.71K | 0.01% | 624 |
|
|
2023
Q1 | $2.96M | Buy |
600,054
+10,800
| +2% | +$53.4K | 0.01% | 602 |
|
|
2022
Q4 | $3.71M | Sell |
589,254
-41,171
| -7% | -$259K | 0.02% | 412 |
|
|
2022
Q3 | $6.81M | Buy |
630,425
+29,411
| +5% | +$318K | 0.08% | 202 |
|
|
2022
Q2 | $6.85M | Sell |
601,014
-100,039
| -14% | -$1.14M | 0.08% | 213 |
|
|
2022
Q1 | $6.39M | Sell |
701,053
-2,333
| -0.3% | -$21.3K | 0.1% | 169 |
|
|
2021
Q4 | $10.5M | Buy |
703,386
+305,334
| +77% | +$4.56M | 0.16% | 119 |
|
|
2021
Q3 | $10.2M | Sell |
398,052
-2,100
| -0.5% | -$54K | 0.23% | 96 |
|
|
2021
Q2 | $10.4M | Sell |
400,152
-1,450
| -0.4% | -$37.8K | 0.23% | 89 |
|
|
2021
Q1 | $14.2M | Buy |
+401,602
| New | +$14.2M | 0.34% | 63 |
|